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Abstract
Cyto-nuclear shuttling of b-catenin is at the epicenter of the canonical Wnt pathway and mutations in genes that result in
excessive nuclear accumulation of b-catenin are the driving force behind the initiation of many cancers. Recently, Naked
Cuticle homolog 1 (Nkd1) has been identified as a Wnt-induced intracellular negative regulator of canonical Wnt signaling.
The current model suggests that Nkd1 acts between Disheveled (Dvl) and b-catenin. Here, we employ the zebrafish embryo
to characterize the cellular and biochemical role of Nkd1 in vivo. We demonstrate that Nkd1 binds to b-catenin and prevents
its nuclear accumulation. We also show that this interaction is conserved in mammalian cultured cells. Further, we
demonstrate that Nkd1 function is dependent on its interaction with the cell membrane. Given the conserved nature of
Nkd1, our results shed light on the negative feedback regulation of Wnt signaling through the Nkd1-mediated negative
control of nuclear accumulation of b-catenin.
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Introduction
Wnt signaling is involved in many aspects of development and
again in the homeostasis of certain stem cells in the adult, such as
those found in hematopoietic, hair follicle and intestinal crypt stem
cells [1,2,3,4]. Consequently, dysregulation of Wnt signaling
during development or in the adult can cause disease [1,5,6].
Under normal conditions, canonical or Wnt/b-catenin signaling is
initiated upon Wnt ligands binding to their transmembrane
receptors. This activates Disheveled (Dvl), which then inhibits the
constitutively active destruction complex consisting of Axin,
GSK3b and APC. Inhibition of this destruction complex results
in cytoplasmic accumulation of b-catenin, which then translocates
into the nucleus to activate its transcriptional program. Two
consistent, and perhaps universal targets of Wnt signaling are the
negative feedback regulators Naked Cuticle Homolog 1 (Nkd1)
and Axin2 [7,8,9,10].
Whereas it has been demonstrated that Axin2 functions
similarly to Axin1, by binding to b-catenin and inducing its
degradation [11,12], the mechanism by which Nkds antagonize
Wnt signaling is less understood. In vertebrates, there are two Nkd
homologues: Nkd1 and Nkd2, which are equally similar to Naked
Cuticle sharing approximately 45% amino acid identity and we
previously demonstrated that both can inhibit canonical Wnt/b-
catenin and non-canonical Wnt/PCP signaling [9]. But there are
significant expression and functional differences between the two
homologues to strongly suggest that Nkd1 is the Naked Cuticle
orthologue. First, nkd1 expression recapitulates many, if not all, of
the known Wnt signaling events during development [9,10,13] and
is upregulated in cancers that are known to have activating
mutations in the Wnt/b-catenin pathway [14,15]. In contrast, nkd2
expression does not appear to be under the control of Wnt
signaling [9,13,16]. Functionally, Nkd2 can regulate Wnt signaling
specifically by targeting Dvl1 for degradation [17]. But Nkd2 also
has a role in escorting TGFa to the basolateral surface of polarized
epithelial cells [18,19,20,21]. In contrast, Nkd1 does not share
these functions with Nkd2 [20] and thus far Nkd1 appears specific
for Wnt signaling [14,22].
Previous work in Drosophila has established that Nkd acts
between Dvl and b-catenin, and its inhibitory activity is dependent
on intact and active Wnt signaling [23]. Subsequent work has
suggested that Nkd has a nucleo-cytoplasmic role, shuttling either
Dvl or other signaling components out of the nucleus [24]. In both
Drosophila and in mammalian in vitro assays, Nkd was found to
interact physically with the PDZ domain of Dvl [22,23] and Dvl
binds Nkd/Nkd1 in at least two domains: a conserved region
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half of Nkd1 [10,20,22]. In Drosophila, the EF-Hand of Nkd alone
is required for binding to Dvl [25], but curiously, Nkd mutant
proteins lacking the EF-Hand are capable of rescuing nkd-/-
mutants to adulthood [26]. This suggests that in Drosophila the
interaction between Nkd and Dvl is dispensable for Nkd activity.
Previously we demonstrated that Nkd2 is myristoylated. This
modification targets Nkd2 to the plasma membrane and is
required for its proper function [20]. While the myristoylation
sequence is conserved in Nkd1, it is not conserved in fly Nkd.
Nevertheless, fly and mosquito Nkds share a unique N-terminal
sequence that confers functional properties and membrane
association to Nkd [27].
Further insight into Nkd1 function was recently gained using an
integrated physical and functional screen to identify Wnt inhibitors
[28]. Using this approach, it was found that Nkd1 interacts with
Axin and this interaction is required to antagonize Wnt signaling.
In this screen, it was also found that Nkd1 had a significant
interaction with b-catenin but it is unknown if this is dependent on
Axin or vice versa [28]. These recent findings imply that Nkd1 is
not acting solely at the level of Dvl and that its interactions with
other components of the Wnt/b-catenin pathway are likely
involved in the ability of Nkd1 to inhibit Wnt signaling.
To probe further the functional significance of the Nkd1-b-
catenin interaction in vivo, we employed the zebrafish model. At
dome stage, which is approximately 4.3 hours post fertilization
(hpf), the zebrafish blastula contains approximately 4000 to 8000
pluripotent cells that have yet to undergo differentiation or
gastrulation [29]. At this stage, the embryo has been undergoing
active zygotic transcription for about 1.3 hours [30], but is only
initiating the first zygotic canonical Wnt/b-catenin signaling
event, via Wnt8, along the ventro-lateral margin [9,31,32]. While
endogenous canonical Wnt/b-catenin signaling is only occurring
along the ventro-lateral margin, the entire blastula at this stage is
responsive to canonical Wnt/b-catenin signaling [33,34]. Further-
more, the non-canonical Wnt/PCP pathway is not yet active at
this stage and so we took advantage of these canonical Wnt/b-
catenin-responsive cells to delineate the function of Nkd1 in
antagonizing canonical Wnt/b-catenin signaling, hereafter re-
ferred to as Wnt signaling. Using this system and overexpression
assays, we demonstrate that Nkd1 interacts with b-catenin and acts
to prevent b-catenin from accumulating within the nucleus. These
results provide insight into the negative feedback mechanism of
endogenous Wnt signaling in an in vivo model, specifically at the
level of cyto-nuclear distribution of b-catenin.
Results
Myristoylation sequence is required for plasma
membrane localization
The N-terminal myristoylation sequence is highly conserved
between vertebrate Nkd homologues and it has been previously
demonstrated that human Nkd2 is myristoylated [9,20]. Thus, we
wanted to determine if zebrafish Nkd1 is plasma membrane bound
and if this is myristoylation sequence dependent. Immunohisto-
chemical analysis of mosaically overexpressed Nkd1
GFP (C-
terminal GFP tag) showed enriched protein expression at the
plasma membrane at dome stage (4.3 hpf) (Fig. 1A). In addition,
there were also large and small GFP positive puncta within the
cytoplasm, reminiscent of Dvl puncta (Fig. 1A) [35,36]. To
confirm that Nkd1 is plasma membrane localized, zebrafish
blastula (4.3 hpf) overexpressing Nkd1
myc (C-terminal myc tag)
alone or with Wnt8 were homogenized and the lysate was
fractionated to isolate the plasma membrane and cytoplasmic
fractions (Fig. 1C). Consistent with the immunohistochemistry
data, we found Nkd1
myc to be enriched within the plasma
membrane fraction, although some Nkd1
myc was also detected in
the cytoplasmic fraction (Fig. 1C). Co-injection of wnt8 RNA did
not appear to alter the overall levels of plasma membrane or
cytoplasmic Nkd1
myc. To determine if the above subcellular
distribution of Nkd1 was dependent on myristoylation, we mutated
the second amino acid, glycine, to alanine (G2A) to generate
Nkd1
G2A-GFP or Nkd1
G2A-myc. This mutation abolishes the
myristoylation activity of human Nkd2 [20]. In contrast to
Nkd1
GFP, Nkd1
G2A-GFP was no longer plasma membrane-
enriched and no longer formed the cytoplasmic puncta as assayed
by immunohistochemistry (Fig. 1B). Instead, Nkd1
G2A-GFP became
evenly distributed within the cytoplasm and possibly in the nucleus
as well. Fractionation experiments confirmed the loss of plasma
membrane association, as there was dramatically less plasma
membrane enrichment of Nkd1
G2A-myc relative to Nkd1
myc
(Fig. 1C). The fractionation data also revealed that a portion of
Nkd1
G2A-myc still segregated with the plasma membrane fraction,
which was not obvious by immunohistochemistry (Fig. 1 B,C).
We also noticed that the levels of cytoplasmic plus membrane
Nkd1
G2A proteins did not add up to the levels detected in the
whole cell lysate when compared to wild-type Nkd1 by Western
blot analysis. We generated a Nkd1
G2P mutant form and observed
that it was also unstable in our fractionation experiments (not
shown), even though a proline at the N-terminal end of proteins is
predicted to be stable [37]. This suggests that the fractionation
procedure is unfavorable to Nkd1
G2A/P stability. In general, we
found that Nkd1 was more stable than Nkd1
G2A (TVR submitted)
and so more Nkd1
G2A RNA was injected to compensate for this
difference.
Nkd1 Myristoylation is required to antagonize Wnt
activity
To ascertain if the myristoylation sequence of Nkd1 was
required for antagonizing Wnt activity, we overexpressed Nkd1
and Nkd1
G2A and assayed for mkp3 expression by whole mount in
situ hybridization at sphere stage (3.8. hpf). At this stage, mkp3 is a
direct target of the maternal Wnt/b-catenin pathway [38] but
shortly after becomes regulated by FGF signaling [38]. We
observed that Nkd1
G2A had very little effect on mkp3 expression in
contrast to Nkd1 overexpression, which led to a reduction in mkp3
expression (Fig. 1 D–F). This was confirmed using quantitative
RT-PCR (qRT-PCR). Total RNA from embryos injected with
either nkd1
GFP or nkd1
G2A-GFP RNA was assayed for endogenous
nkd1 expression at dome stage (4.3 hpf) as readout of active Wnt
signaling (Fig. 1G). Consistent with the whole mount in situ
hybridization data, we observed that Nkd1
GFP could reduce the
expression of a Wnt target gene, while a myristoylation-deficient
form of Nkd1 (Nkd1
G2A) was less effective at doing so.
To determine if Nkd1
G2A could prevent the activation of target
genes induced by excess Wnt signaling, we performed qRT-PCR
on embryos co-injected with wnt8 and nkd1
GFP or nkd1
G2A-GFP
RNAs. For comparison we also co-injected wnt8 and axin1 RNA,
the latter encoding a potent inhibitor of Wnt signaling (Fig. 1H,I).
We observed that Nkd1
GFP and Axin1 reduced the effect of
ectopic Wnt8 on endogenous nkd1 expression, with Nkd1
GFP
having slightly less influence than Axin1. In contrast, Nkd1
G2A-GFP
was markedly less active in this assay (Fig. 1H,I). Therefore, we
conclude that myristoylation of Nkd1 is required for its ability to
antagonize Wnt signaling, suggesting that plasma membrane
association of Nkd1 is critical for its activity. The latter conclusion
is similar to results found in Drosophila where removal of the N-
terminal sequence of Nkd abrogated both its plasma membrane
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Nkd isoform was also much less stable [27]. This argues for
conservation of function, as both fly and vertebrate Nkd/Nkd1
appear to require association with the plasma membrane for
proper activity in antagonizing Wnt signaling.
Nkd1 binding to Dvl2 is independent of myristoylation
Previous studies have demonstrated that Nkds bind Dvl proteins
[10,22,23,39]. Therefore, we wanted to determine if Dvl binding
was dependent on Nkd1 myristoylation. Immunohistochemistry of
blastula (4.3 hpf) overexpressing Nkd1
myc and Dvl2
HA in a mosaic
fashion showed that Dvl2
HA co-localized with Nkd1
myc at the
plasma membrane but also in cytoplasmic puncta (Fig. 2A–C). It is
possible that Nkd1
myc stabilized Dvl2
HA at the plasma membrane,
as adjacent cells expressing Dvl2
HA alone exhibited low plasma
membrane staining (arrowheads in Fig. 2A–C). In contrast,
immunohistochemistry with Dvl2
HA and Nkd1
G2A-myc demon-
strated that cells co-expressing both Dvl2
HA and Nkd1
G2A-myc, but
not Dvl2
HA alone, have lost the Dvl2
HA puncta staining (compare
arrows and arrowheads, Fig. 2D–F), arguing that Nkd1
G2A-myc can
still bind to Dvl2
HA and dissociate Dvl2
HA puncta.
To confirm that Nkd1
myc interacts with endogenous Dvl2 and
to determine if Nkd1
G2A-myc can also bind to endogenous Dvl2, we
performed co-immunoprecipitation assays. Consistent with the
immunohistochemistry data, we observed that Nkd1 could
interact with Dvl2 independent of its myristoylation, but the
molecular weights of Dsh
HA were different between Nkd1
myc and
Nkd1
G2A-myc (Fig. 2G). We observed Nkd1
myc immunoprecipitat-
ed with Dvl2 isoforms that migrate with different mobilities, when
compared to those complexed with Nkd1
G2A-myc (Fig. 2G).
Nkd1
GFP interacted with both slow and fast migrating isoforms
of Dvl2, while Nkd1
G2A-GFP interacted preferentially with the fast
migrating isoform. To pursue the effect of Nkd1 on Dvl2 further,
we co-injected RNAs encoding nkd1
GFP or nkd1
G2A-GFP with wnt8
RNA and fractionated the embryo lysates to observe the plasma
membrane and cytoplasmic forms of Dvl2. In the cytoplasmic
Figure 1. Plasma membrane localized Nkd1 is required for antagonizing Wnt signaling. nkd1
GFP (A) or nkd1
G2A-GFP (B) mRNA was injected
into 1 of 4 blastomeres and allowed to develop until dome stage (4.3 hpf). Embryos were viewed live with confocal microscopy. (C) In a similar
experiment, embryos injected at the one cell stage with either nkd1
myc or nkd1
G2A-myc in combination with wnt8, were collected at dome stage and
fractionated into cytoplasmic (cyto) or plasma membrane (mem) fractions. Western blots of fractions were probed with anti-myc. This blot was also
probed with anti-actin or anti-pancadherin to determine purity of fractions. Each lane represents the equivalent of 1 embryo from an average of 10
embryos. To determine total amount of protein, a portion of the pre-fractionated whole cell lysate (wcl) was western blotted and probed with anti-
myc and anti-actin as a loading control. For the wcl, each lane represents the equivalent of 0.75 of an embryo from an average of 10 embryos. (D, E, F)
Embryos were injected at the one cell stage with either nkd1 (E) or nkd1
G2A (F) RNA and harvested, along with uninjected controls (D), at sphere stage
(3.8 hpf). Embryos were processed for whole mount in situ hybridization using a mkp3 anti-sense probe [38]. The schematic below (F) summarizes the
whole mount in situ hybridization data, identifies the different regions of the embryo and the domain of mkp3 expression in the dorsal organizer
region. (G) Embryos were injected at the 1 cell stage with nkd1
GFP or nkd1
G2A-GFP, harvested at dome stage and total RNA was isolated and reversed
transcribed. qRT-PCR was performed using endogenous nkd1 as readout. The 59 untranslated region of nkd1 was used as a target, the sequence of
which was not incorporated into the expression vectors. Values are relative to uninjected embryos which was arbitrarily set to 1 (N=3). (H)
Quantification of endogenous nkd1 levels by qRT-PCR in the presence of Wnt8. (N=6 for Wnt8; Wnt8+Nkd1
GFP; Wnt8+Nkd1
G2A-GFP). The Wnt8+Axin
experiments (N=3) were done independently of the others, which showed higher induction of nkd1 by Wnt8 alone, compared to the other
experiments and relative to uninjected. (I) To adjust for the differences between experiments described in (H), the ratio of endogenous levels of nkd1
was determined for Wnt8+Nkd1
GFP:Wnt8 (N=6), Wnt8+Nkd1
G2A-GFP:Wnt8 (N=6) and Wnt8+Axin1:Wnt8 (N=3) for each individual experiment and
then averaged. (*=Students t-test, p=0.0252). A level of one indicates no effect. Error bars represent standard error. Scale bar in A,B represents
10 mm.
doi:10.1371/journal.pone.0018650.g001
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phosphorylation in the presence of Wnt8 [40,41,42,43], which was
also observed for the two Nkd1 constructs (Fig. 2H). In agreement
with the co-immunoprecipitation experiment, we also observed
different banding patterns in the plasma membrane fractions of
Dvl2 between Nkd1
GFP and Nkd1
G2A-GFP, which appear inde-
pendent of the addition of Wnt8 (Fig. 2H). Specifically, we
observed an increase in intensity of the slower and intermediate
Figure 2. Nkd1 co-localizes with Dvl2. (A–F) Dvl2
HA mRNA was injected at the one cell stage followed by injection of nkd1
myc or nkd1
G2A-myc RNA
into 1 of 4 blastomeres at the 4-cell stage. Embryos were harvested at 50% epiboly (5.25 hpf) and processed for immunohistochemistry using anti-
myc probes (red) or anti-HA probes (green). Arrowheads in A-F identify a cell that is positive for Dvl2
HA but negative for Nkd1
myc (A–C) or Nkd1
G2A-myc
(D–F). Arrow in D–F indentifies a cell that is positive for both Dvl2
HA and Nkd1
G2A-myc. (G–H) Nkd1 interacts with Dvl2. (G) Embryos were injected at
the one cell stage with nkd1
myc or nkd1
G2A-myc and harvested at dome stage (4.3 hpf) for co-immunoprecipations. Lysates were incubated with anti-
zDvl2 or anti-myc antibodies for immunoprecipitation. Immunoprecipitates were western blotted and probed with anti-zDvl2 or anti-myc antibodies
(WB). Each lane represents the equivalent of 17.5 embryos. (H) nkd1
GFP or nkd1
G2A-GFP RNAs were co-injected with wnt8 RNA at the one cell stage. At
4.3 hpf, embryos were harvested and fractionated to isolate cytoplasmic (cyto) and plasma membrane (mem) fractions. Anti-actin and anti-pan-
cadherin antibodies determined the purity of the cytoplasmic and plasma membrane fractions, respectively. A portion of the whole cell lysate was
recovered prior to fractionation (lower panel) to determine loading controls. (Note: the high percentage gel precluded observing Dvl mobility shifts
induced by Wnt8 in the whole cell lysate). The predicted MW of Nkd1
myc is 61 kD, but the observed MW is closer to 75 kD. We speculate that this is
likely due to post-translational modifications of Nkd1. Each lane represents the equivalent of 1 embryo, averaged from 10 embryos. Scale bar
represents 20 mm.
doi:10.1371/journal.pone.0018650.g002
Nkd1 Antagonizes Nuclear Accumulation of b-Catenin
PLoS ONE | www.plosone.org 4 April 2011 | Volume 6 | Issue 4 | e18650migrating bands in the presence of Nkd1
GFP, but an increase in a
fast migrating band of Dvl2 in the presence of Nkd1
G2A-GFP when
compared to uninjected or wnt8 RNA alone injected embryos
(Fig. 2H).
The differences in plasma membrane vs cytoplasmic levels of
Dvl2 observed by western blot analysis did not exactly correlate
with the immunohistochemical data (Fig. 2) as we did not see an
increase in endogenous Dvl2 in the membrane fraction by
western, while we observed increased membrane localization with
exogenous Dvl2
HA by immunohistochemistry. This may be due to
fundamental differences between ectopic and endogenous Dvl2, or
that membrane association of Dvl2 is lost during the fractionation
process. Nonetheless and taken together, this data suggests that
Nkd1
GFP modifies, interacts with or stabilizes different isoforms of
Dvl2. While Nkd1
G2A-GFP also interacts with Dvl2, it is doing so
differently than Nkd1
GFP. This is consistent with the ability of
Nkd1, but not Nkd1
G2A, to inhibit ectopic Wnt8 signaling (Fig. 1I).
Nkd1 does not alter cytoplasmic levels of b-catenin
Thus far, we have determined that plasma membrane
localization of Nkd1 is required for its activity to antagonize
Wnt signaling. We have also demonstrated that Nkd1 binds to and
somehow modifies, interacts with, or stabilizes different Dvl2
isoforms. These specific interactions and modifications also appear
to occur at the plasma membrane. A model based on genetic
epistasis studies suggests that Nkd1 acts between Dvl and b-catenin
[23], with the simplest and most attractive model being that Nkd1
acts at the level of Dvl, somehow binding to and inactivating Dvl
[10,23,24,26,27,44]. If Nkd1 is indeed antagonizing Wnt signaling
at the level of Dvl, then Nkd1 should prevent the accumulation of
cytoplasmic b-catenin induced by Wnt8. To test this model, we co-
injected nkd1 or nkd1
G2A RNAs (either with myc or GFP tags) with
or without wnt8 RNA, isolated the cytoplasmic fraction and
assayed for b-catenin by Western blot (Fig. 3A). Inconsistent with
the model described above, we observed no decrease in
cytoplasmic b-catenin levels in the presence of Nkd1 or Nkd1
G2A
with or without Wnt8 (Fig. 3A,C,D). To determine that this is
qualitatively different than Axin, we next compared the effect of
Nkd1 to Axin1. Consistent with the known function of Axin1, we
observed reduced cytoplasmic levels of b-catenin induced by Wnt8
in the presence of Axin1 (Fig. 3B,D). These experiments were
repeated 6 times with similar results (Fig. 3C; Table 1). Taken
together, we conclude that while the constitutively active Axin1
destruction complex destabilizes cytoplasmic b-catenin, Nkd1 does
not appear to antagonize the Wnt pathway at this level, arguing
that Nkd1 may instead be acting downstream of stabilized
cytoplasmic b-catenin.
Nkd1 prevents Wnt8-induced nuclear accumulation of
b-catenin
As Nkd1 does not significantly alter the levels of cytoplasmic b-
catenin, we wanted to determine if Nkd1 altered the levels of
nuclear b-catenin. To test this we overexpressed Wnt8 with or
without Nkd1
myc or Nkd1
G2A-myc and performed whole mount
immunohistochemistry against b-catenin at dome stage (4.3 hpf).
GFP mock-injected embryos displayed nuclear b-catenin around
the perimeter of the embryo as a result of endogenous ventro-
lateral Wnt8 activity (Fig. 4A,B) [32]. However, there was a
complete absence of nuclear b-catenin in cells at the animal pole at
this stage (Fig. 4A,B,J). Injection of wnt8 RNA alone induced
nuclear b-catenin in the majority of cells in the animal pole region
at this stage (Fig. 4C,J). Injection of nkd1
myc or nkd1
G2A-myc RNA
alone had only a modest effect on ventro-lateral nuclear b-catenin,
consistent with our previous observations (Fig. 4D,E,J) [9]. In
contrast, injection of axin1 RNA resulted in significantly fewer
ventro-lateral cells with nuclear b-catenin (Fig. 4J). When RNAs
encoding wnt8 and nkd1
myc were co-injected, there was a substantial
reduction in both ectopic and ventro-lateral nuclear b-catenin
(Figs. 4F,J). In contrast, ectopic Nkd1
G2A-myc was unable to
prevent the accumulation of nuclear b-catenin induced by Wnt8
overexpression (Fig. 4G,J). This data was consistent across
numerous embryos and experiments (Fig. 4J and Table 2). Based
on these results, we suggest that Nkd1 functions upstream of
nuclear accumulation of b-catenin and potentially functions by
preventing nuclear accumulation of b-catenin.
To test further the hypothesis that Nkd1 functions at the level of
nuclear b-catenin accumulation, we co-injected RNAs encoding
wnt8 and nkd1
GFP or wnt8 and nkd1
N-GFP (an N-terminal GFP fusion
and more stable form of myristoylation deficient Nkd1) into 1 of 4
blastomeres at the 4-cell stage. We reasoned that if Nkd1
GFP
somehow affects nuclear b-catenin, we would predict GFP positive
cells to have reduced levels of nuclear b-catenin, compared to
juxtaposed, GFP negative cells, which would have elevated levels
of nuclear b-catenin due to the non-cell autonomous effects of
Wnt8. Accordingly, we observed a decrease in nuclear b-catenin
in Nkd1
GFP positive cells, compared to juxtaposed and surround-
ing cells that were GFP negative (Fig. 4K,M,N). As the nucleus of
every cell is not in the same plane of focus, we stained the nuclei
with Hoechst, a general DNA marker, and adjusted the level of b-
catenin staining intensity according the Hoechst staining intensity
(Fig. 4M, S1). The Hoechst staining confirmed that nuclei in the
Nkd1
GFP positive cells were visible and that they had significantly
less b-catenin staining when compared to juxtaposed GFP
negative cells (Fig. 4N, S1).
In contrast, Nkd1
N-GFP was much less efficient at reducing the
levels of nuclear b-catenin (Fig. 4L,N). We conclude that
myristoylated Nkd1 likely acts downstream of stabilized cytoplas-
mic b-catenin, preventing its nuclear accumulation.
Nkd1 physically interacts with b-catenin
b-catenin is at the center of the canonical Wnt signaling cascade
and the nucleo-cytoplasmic shuttling of this protein is the focus of
recent research [45,46]. We found that while Nkd1 is enriched at
the plasma membrane with cytoplasmic puncta, it does not appear
to alter cytoplasmic levels of b-catenin (Fig. 3A). Instead our
studies suggest that Nkd1 prevents the nuclear accumulation of b-
catenin. Therefore, we wanted to determine if there was a physical
interaction between Nkd1
myc and b-catenin. By co-immunopre-
cipitation, we observed a strong interaction between Nkd1
myc and
b-catenin, but a much weaker interaction between Nkd1
G2A-myc
and b-catenin (Fig. 5A). This suggests that Nkd1 myristoylation
and its association with the plasma membrane is important for
binding to b-catenin, although we do not know if this a direct or
indirect interaction. We also observed an increase in Nkd1-b-
catenin interaction in the presence of Wnt8 (Fig. 5B); however, it is
unclear if this is a result of increased levels of cytoplasmic b-
catenin due to excess Wnt8, or if Wnt signaling alters the affinity of
Nkd1 for b-catenin, or both. Furthermore, these experiments
cannot distinguish which pool of b-catenin (plasma membrane or
cytoplasmic) interacts with which pool of Nkd1 (plasma membrane
or cytoplasmic puncta).
Since Nkd1 also binds to Dvl2, we were curious if we could
observe a ternary complex between Nkd1, Dvl2 and b-catenin.
Immunoprecipitating Dvl2 we detected a low background level of
co-immunoprecipitated b-catenin that did not change in the
presence of Wnt, Nkd1
myc or Nkd1
G2A-myc, whereas the reverse IP
suggested little or no interaction (Fig. 5A). Even though Nkd1 was
found to interact with both Dvl2 and b-catenin (Figs. 2G, 5A), this
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ternary complex and further that Dvl2 and b-catenin may
compete for binding to Nkd1. To test this, we co-injected
increasing amounts of Dvl2
HA and observed a dramatic reduction
in the levels of b-catenin that immunoprecipitated with Nkd1
myc
with increasing amounts of Dvl2
HA (Fig. 5C).
Using human Nkd1 deletion mutants [28], we mapped the
regions of Nkd1 that are required to bind b-catenin. We found
that b-catenin binds to Nkd1 in a conserved region encompassing
the EF-hand (NHR1 domain), as well as in a region C-terminal to
this, which includes a second region of conserved homology
(NHR2) [9]. Further, we found that Dvl2 binds to Nkd1 in a
partially overlapping region with its b-catenin-binding site (Fig. 5D,
S2). Previously we demonstrated that Axin1 binds to Nkd1 via the
C-terminal poly histidine tail on Nkd1 (Fig. 5D) [28]. Our current
analysis demonstrates that this region is not required for binding to
either Dvl2 or b-catenin suggesting that Axin1 binding to Nkd1 is
not a requirement for Nkd1 binding to Dvl2 or b-catenin.
These mapping results support previous findings. Using just the
EF-hand, Wharton et al., found this region was sufficient to bind
Figure 3. Nkd1 does not affect cytoplasmic levels of b-catenin. (A,B) Embryos were injected at the one stage with wnt8, nkd1
myc or nkd1
G2A-myc
(A) or axin1 (B) and harvested at dome stage (4.3 hpf). Lysates were fractionated into plasma membrane (not shown) and cytosolic fractions, Western
blotted and probed with anti-b-catenin, anti-myc and anti-actin antibodies. Each lane represents, on average, the equivalent of one embryo averaged
from 10 embryos. (C) The average levels of cytosolic b-catenin from 6 independent experiments (Wnt8+/- Nkd1
myc/Nkd1
G2A-myc) or from 3 independent
experiments (Wnt8+/-Axin1) were determined. Each lane was first normalized to actin levels and then compared to uninjected embryos, which was
arbitrarily set to 1. D) To adjust for the differences between experiments described in (C), the ratio of cytoplasmic levels of b-catenin was determined for
Wnt8+Nkd1
myc:Wnt8 (N=6), Wnt8+Nkd1
G2A-myc:Wnt8 (N=6) and Wnt8+Axin1:Wnt8 (N=3) for each individual experiment and then averaged.
(**-Students t-test, p=0.0002). A level of one indicates no effect. Error bars represent standard error.
doi:10.1371/journal.pone.0018650.g003
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absence of the EF-hand [22] and we previously found that Dvl
binds a domain in the C-terminal region on Nkd2 [20]. Therefore,
Dvl2 (and b-catenin) bind to regions encompassing the EF-hand
and a separate domain C-terminal to the conserved EF-hand
domain, which includes the NHR2 domain. Fine interaction
mapping of these regions is currently underway, which will
determine more precisely where Dvl2 and b-catenin bind Nkd1
and if these two proteins bind to the same or juxtaposed regions of
Nkd1. Thus, we conclude that the Nkd1-b-catenin interaction is
conserved between zebrafish and mammals. Moreover, our data
also suggests that Dvl2 and b-catenin likely compete for binding to
Nkd1.
Discussion
Activation of canonical Wnt signaling is well characterized and
is considered to proceed through the formation of Wnt-induced
signalosomes [47,48]. What is less well understood is how this
pathway controls its own activity to limit the amount of Wnt
signaling. Here we show that Nkd1, a Wnt-inducible negative-
feedback regulator limits Wnt signaling by preventing nuclear
accumulation of b-catenin. This work furthers our understanding
of the role Dvl plays in this process. We have found that Nkd1
interacts with both a slow and fast migrating form of Dvl2
correlating with phosphorylated and unphosphorylated forms of
Dvl2, respectively [40,41,42,43,49]. In the presence of Nkd1,
exogenous Dvl also becomes enriched at the plasma membrane.
Thus, it appears that plasma membrane localization of Nkd1, via
myristoylation, is required for its association with a slower
migrating (phosphorylated) form of Dvl. This is supported by
our observations that, in the absence of myristoylation, Nkd1
G2A
interacts preferentially with a faster migrating form of Dvl and
both remain uniformly distributed within the cytoplasm. Alterna-
tively, the binding of Nkd1, but not Nkd1
G2A, to Dvl, may lead to
Dvl phosphorylation, but this does not account for the observation
that Nkd1 interacts with both a phosphorylated and unpho-
sphorylated form of Dvl.
Thus far, this data fits well with Nkd1 antagonism occuring at the
level of Dvl, simply inhibiting Dvl in the signalosome. However, this
model cannot account for the lack of effect of Nkd1 on the levels of
cytoplasmic b-catenin. While Axin can effectively reduce the levels
ofcytoplasmicb-catenininducedbyWnt8,Nkd1cannot.Infact,we
often observed slight (but not significant) increases in cytoplasmic b-
catenin in the presence of Nkd1, without Wnt stimulation. Further,
we observed that Nkd1 physically interacts with b-catenin and that
the strength of this interaction is dependent on an intact
myristoylation sequence in Nkd1. This suggests that Nkd1 needs
toassociatewith the plasmamembranebeforeitcaninteract with b-
catenin.Also,wehavedetermined thatb-cateninandDvloverlap in
Nkd1 binding domains, that they likely compete for binding to
Nkd1, and that Wnt signaling may promote binding between Nkd1
and b-catenin. Finally, our observation that Nkd1 inhibits
accumulation of nuclear b-catenin suggests that this effect of
Nkd1 takes place in the cytoplasm.
Recently, Axin1 and Axin2 were also found to interact with
Nkd1 through the C-terminal poly-histidine tail of Nkd1 [28], but
it is not yet clear if this interaction is occurring in the cytoplasm or
at the plasma membrane or both. Axin has been found to form
both plasma membrane localized and intracellular puncta, but
these two domains act opposite to one another with respect to Wnt
signaling. Wnt ligands induce the formation of plasma membrane-
localized Axin clusters which also contain Dvl and LRP5/6
proteins forming a Wnt signalosome [48], while cytoplasmic Axin
clusters co-localize with APC and b-catenin and constitute the
constitutively active destruction complex[50]. Also, it is well
documented that these clusters are aggregates of Wnt signaling
components and not true vesicles [36,48]. Thus, as Nkd1 binds to
Axin [28], Dvl [10,22,23,39] (this study) and b-catenin [28] (this
study), it is likely that the observed Nkd1 puncta are also part of a
Wnt signalosome and/or destruction complex, although this
requires formal testing.
In Drosophila, Nkd was also tested for interactions with Axin
and b-catenin by yeast-2-hybrid but no interaction was detected
[23]. Since we found that membrane localization of Nkd1 is
critical for its interaction with b-catenin, it is possible that the
yeast-2-hybrid environment could not recapitulate a possible
membrane requirement for Drosophila Nkd to interact with b-
catenin. This is supported by the finding that fly Nkd function is
also dependent on its interaction with the membrane [27].
Alternatively, the interaction between Nkd/Nkd1 and b-catenin
requires an intermediate protein, which would be available in vivo,
but not available in a yeast-2-hybrid assay.
Myristoylation of Nkd1 is critical for its activity and to
understand this further, we generated Nkd1 chimeras to target
Nkd1 to the membrane in the absence of myristoylation to
determine if these chimera’s could recapitulate wild type Nkd1
activity. Tagging Nkd1 with alternate membrane localization
motifs (N- or C-terminal Plekstrin Homology domain, a N-
terminal signal sequence with transmembrane motif, and a C-
terminal CAAX domain) could not recapitulate Nkd1 activity and
in all cases could not localize, or only weakly localize, to the
plasma membrane (TVR, LS-K, RJC unpublished data). This
suggests that myristoylation is specifically effective at bringing
Nkd1 to the membrane.
The exact mechanism of Nkd1 action is still unknown, but may
involve the nuclear import machinery. In Drosophila it was found
that Nkd Cuticle binds to Importin alpha3 via its ARM repeats
and that this region in Nkd is critical for its function [24].
Interestingly, Importin alpha3 shares significant homology to b-
catenin specifically in the ARM-repeats and we are currently
testing the hypothesis that Nkd1 and b-catenin interact through
the b-catenin ARM repeats. Fly Nkd also contains nuclear
localization sequences and is observed in the nucleus. While these
nuclear localization sequences are conserved between fly and
Table 1. Relative cytoplasmic levels of b-catenin.
Injection Average Ttest p-values
Uninj 1.0
Wnt8
1 2.4 0.05 {
Nkd1
myc 1.1 0.61 {
Nkd1
G2A-myc 1.2 0.60{{
Wnt8+Nkd1
myc 2.1 0.72{{
Wnt8+Nkd1
G2A-myc 2.0 0.61{{
Wnt8
2 3.2 0.02 {
Axin1 1.4 0.38 {
Wnt8+Axin1 1.1 0.04{{
Averages were taken from 6 (Nkd1
myc or Nkd1
G2A-myc co-injections) or 3 (Axin1
co-injections) independent experiments and first normalized to actin levels.
Uninjected levels were set to 1.00 and other levels are relative to uninjected.
1Nkd1
myc and Nkd1
G2A-myc co-injection series.
2Axin1 co-injection series.
{-Students t-test (2 tailed, equal variance) compared to uninjected;
{{-Students t-test (2 tailed, equal variance) compared to Wnt8 injected.
doi:10.1371/journal.pone.0018650.t001
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Furthermore, suppression of nuclear export in Drosophila cells did
not result in nuclear accumulation of Drosophila Nkd [26], arguing
against a role for Nkd in the nucleus. While we can not rule out a
role for vertebrate Nkd1 in the nucleus, the absence of conserved
nuclear localization sequences and the presence of a myristoyl
moiety suggests that, at least in zebafish blastula cells, Nkd1 is
unlikely to have a significant role in the nucleus.
Our observations that Nkd1 has a more dramatic effect on
ectopic Wnt signaling compared with endogenous Wnt signaling
appears to reflect an evolutionarily conserved phenomenon. In fly,
Nkd is only required during early segmentation of the Drosophila
embryo and not during other aspects of development involving
Wg signaling [51]. In vertebrates knockout of both Nkd1 and
Nkd2 has no overt phenotype [52]. We have also knocked down
zebrafish Nkd1 and Nkd2 and observed modest, but significant,
Figure 4. Nkd1 inhibits accumulation of nuclear b-catenin. (A–I) Embryos were injected at the one cell stage with mRFP (A,B); wnt8+mRFP (C);
nkd1
myc (D); nkd1
G2A-myc (E); wnt8+nkd1
myc (F); wnt8+nkd1
G2A-myc (G); wnt8+axin1 (H); and axin1 alone (I). At dome stage (4.3 hpf) embryos were
collected and processed for whole-mount immunohistochemistry with anti-b-catenin. The expression of nuclear b-catenin around the ventro-lateral
margin of the embryo is due to endogenous Wnt8 activity. Note that Axin1 is also sufficient to prevent nuclear localization of b-catenin induced by
endogenous Wnt8 activity. The box in (A) represents the size and position of analysis for (J). The rectangle in (A) depicts the regions shown in (B–I)
which encompasses the ventro-lateral margins on either side of the embryo. (J) Blind counts of the number of cells expressing ectopic nuclear b-
catenin was quantified (Table 2). Error bars represent standard error. To confirm the effect of Nkd1 on nuclear b-catenin, wnt8 RNA was co-injected
with nkd1
GFP (K) or nkd1
N-GFP RNA (L) into 1 of 4 blastomeres, harvested at dome stage and processed for endogenous b-catenin staining. Regions of
mosaic expression were chosen for analysis. Clones of Nkd1
GFP or Nkd1
G2A-GFP positive clones are outlined in white. Black and white images of GFP
and b-catenin are shown for contrast. See also Fig. S1 for the complete set of images. (M-N) Quantification of the differences in nuclear b-catenin from
six cells (Wnt8+Nkd1
GFP) or 10 cells (Wnt8+Nkd1
N-GFP) cells each for GFP positive/Hoechst positive and juxtaposed GFP negative/Hoechst positive
cells. The graphs in (M) represents the two cells identified by asterisks in the right hand-most image of (K). The dashed lines delineate the nuclear grey
levels. (N) The level of nuclear b-catenin was adjusted using the Hoechst staining. Only the grey values located between the dashed lines were
evaluated. (p value =0.0002). Error bars represent std error. Scale bar represents 20 mM.
doi:10.1371/journal.pone.0018650.g004
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Nkd2 by itself does not have a dramatic or consistent phenotype in
wild-type embryos [9,51]. Only under compromised Wnt signaling
conditions do we observe Nkd1 function, either by overexpression
of Wnt or by genetic manipulation that results in reduced or
ectopic Wnt signaling [9] (this study and TVR, LS-K, RJC
unpublished). This is entirely consistent with observations in
Drosophila [23,51] and suggests that there is a threshold of Wg/
Wnt signaling upon which Nkd functions. We predict that this
threshold would be lower in a Wg/Wnt sensitized background.
This could explain the subtle loss of function phenotype in the
Nkd1/Nkd2 double knockout mouse if this threshold is never
perturbed under normal physiological conditions, or why there are
not additional nkd-/- phenotypes in the developing Drosophila
embryo.
In conclusion, we have demonstrated that in zebrafish blastula
cells, Nkd1 prevents nuclear accumulation of b-catenin and that
this function of Nkd1 is dependent on its plasma membrane
localization via myristoylation. Furthermore, we also found Nkd1
to interact with b-catenin and that Dvl2 and b-catenin may
compete for binding to Nkd1. The functional significance of Nkd1
interacting with b-catenin, Dvl2 and Axin is currently under
investigation.
Materials and Methods
Quantitative RT-PCR
Total RNA from embryos was prepared using Trizol (Gibco).
cDNA was synthesized with Superscript II (Invitrogen). Quanti-
tative RTPCR (qRT-PCR) was performed using IQ Syber green
(BioRad). Three replicates were performed for each experiment.
Sequences of primers were as follows. b-Actin Forward: 59-
ATGCCCCTCGTGCTGTTTT-39; b-Actin Reverse: 59-TCT-
GTCCCATGCCAACCAT-39; Nkd1-59UTR Forward 59- AAG-
CCGCGCGCTCTTC-39; Nkd1-59UTR Reverse 59- GAAA-
CATCAGAAACAAAAAACAATCC-39; Axin2 Forward: 59-AT-
GCCCCTCGTGCTGTTTT-39; Axin2 Reverse 59-TCTGTC-
CCATGCCAACCAT-39. Absolute quantification was deter-
mined using a standard curve generated by b-actin. Relative
quantitative RT-PCR (qRT-PCR) was determined by normalizing
to uninjected.
Constructs
Nkd1
G2A constructs were generated by site directed mutagen-
esis. Constructs were cloned into the ClaI site of pCS2+myc or
pCS2+GFP. Mutagenesis primers are as follows Nkd1
G2A For 59-
GCAGGATCCCATCGATGATGGCTAAACTTCATTCC-39;
Nkd1
G2A Rev 59- GGAATGAAGTTTAGCCATCATCGATG-
GGATCCTGC-39; Orientation and sequence integrity were
confirmed by sequencing. pCS2+Axin1 was kindly provided by
Toshio Hirano [33]. pCS2+Wnt8 was kindly provided by Randall
Moon [31,53].
mRNA injections
Capped mRNA was synthesized and purified using Ambion’s
mMessage mMachine kit following their protocol. mRNA was
diluted in RNase free water, and its quantity and quality was
analyzed by spectrophotometer and RNase free gel analysis. For
all of the experiments, except where noted, 800 pg of nkd1
myc,
nkd1
GFP; nkd1
N-GFP;o r1200 pg nkd1
G2A-myc or nkd1
G2A-GFP; 25 pg
wnt8; 100 pg dsh2-
HA; 400 pg axin1 in 1% phenol red were
pressure injected into the yolk cell of one- to two-cell-stage
embryos. For immunohistochemistry on nuclear b-catenin, a
mixture of 25 pg wnt8 and 100 pg of nkd1
GFP or nkd1
N-GFP was
pressure injected into one of four blastomeres.
Fractionations
Ten embryos were harvested at dome stage (4.3 hpf),
mechanically dechorionated and deyolked in 0.3X Danieau.
Deyolked animal caps were lysed by trituration in TKM buffer
(50 mM Tris-HCl 7.5; 25 mM KCl; 5 mM MgCl2; 1 mM EGTA;
0.02% Na Azide) containing CompleteH Protease Inhibitor
(Roche). Lysates were centrifuged at 1000g for 5 min at 4uCt o
pellet nuclei, large membrane fragments and whole cells. The
resulting lysate was further fractionated into crude plasma
membrane and cytoplasmic fractions by centrifugation at
100,000g for 1 hr at 4uC.
Immunoprecipitations
Cells were lysed through an 18 guage needle in modified
Rubenfelds buffer [54] (modification: 0.3% NP-40 replaced 1%
Triton-X) containing Complete Protease InhibitiorH (Roche).
Primary antibodies consisted of (monoclonal anti-b-catenin,
Sigma; monoclonal anti-myc 9E10, Vanderbilt Antibody Core;
polyclonal anti-Dvl2 generated against the zebrafish Dvl2 peptide
HSSGSTRSDGEKKRRGPKSVSE, corresponding to amino
acids 573–592 and conjugated on the C-terminus with a Cysteine
(Covance).
Western Analysis
Monoclonal anti-myc 9E10 1:2000; monoclonal anti-b-catenin,
1:1000; polyclonal anti-GFP (Torrey Pines) 1:1000, polyclonal
anti-pan-cadherin (Abcam) 1:1000, monoclonal anti-actin (Sigma)
1:2000; polyclonal anti-Dvl2 1:5000; anti-HA (Vanderbilt Anti-
body Core) 1:1000.
Immunohistochemistry
Primary antibodies: mouse anti-myc 1:500; Rat anti-HA 1:200;
Rabbit anti-zDvl2 1:1000 or 1:5000; mouse anti-b-catenin 1:250).
Secondary antibodies: Cy2 Donkey anti-Rat 1:200; Cy3 Goat
anti-mouse 1:200; Cy3 Goat anti-Rabbit 1:200; Cy2 Goat anti-
Rabbit 1:200; AlexaFluor 594 1:200; syto59 1:10,000.
Nuclear b-catenin
Whole mount immunhistochemistry: Nuclear b-catenin staining
was carried out using the Vectastain Elite ABC kit (Vectastain
Laboratories) along with Avidin D (blocking kit, Vectastain
Laboratories) and ImmPact DAB (Vectastain Laboratories).
Table 2. Nuclear b-catenin counts.
Injection
Ave # cells with
Nuclear b-catenin
number of
embryos
Ttest
p-values*
mGFP 2.00 6
Wnt8 179.22 9
Nkd1
myc 2.00 6
Nkd1
G2A-myc 2.00 6
Wnt8+Nkd1
myc 97.00 6 0.002794
Wnt8+Nkd1
G2A-myc 187.00 10 0.346332
Wnt8+Axin 80.67 6 0.000144
Axin 2.00 6
Nuclear b-catenin counts from the central square shown in figure 4. * Students
t-test (2 tailed, equal variance) compared to Wnt8 injected.
doi:10.1371/journal.pone.0018650.t002
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catenin, 6 cells Nkd1
GFP positive and 6 juxtaposted GFP negative
cells, and 10 cells for Nkd1
N-GFP positive and juxtaposed GFP
negative cells were analyzed. Grey scales for Nuclear Hoechst and
nuclear b-catenin where calculated using Image J. They grey levels
of signal intensity were measured across the cell for both the
Hoechst staining and the b-catenin staining. For each cell, the
average level of b-catenin in the nuclei was normalized to its
Hoechst staining. The adjusted averages were then plotted and
compared by students T-test.
Nkd1 Interaction Mapping
Immunoprecipitation (IP) and immunoblotting (IB) were carried
out using an anti-flag antibody (Sigma #F3165; 1:1000 IP, 1:3000
IB). LUMIER experiments were performed as previously
described [28,55].
Figure 5. Nkd1 interacts with b-catenin. To determine if Nkd1 and b-catenin interact, wnt8 +/2 nkd1
myc or nkd1
G2A-myc was injected at the 1 cell
stage and harvested at dome stage for immunoprecipitation with anti-b-catenin (A). Each lane represents the equivalent of 17.5 embryos. Note, this
experiment was part of a larger experiment involving the co-immunoprecipitations shown in Fig. 2 (B) and as such share some of the same controls.
(B) nkd1
myc +/2 wnt8 was injected into 1 cell stage embyros and harvested at dome stage, immunoprecipitated with anti-myc and western blotted
with anti-b-catenin. The interaction between Nkd1 and b-catenin is much stronger in the presence of exongenous Wnt. Slight non-specific binding of
the anti-myc antibody is observed in the control lane. A no primary antibody control showed no banding pattern (not shown). C) nkd1
myc was co-
injected with increasing doses of dsh
HA (0pg, 125pg and 250pg) harvested at dome stage, immunoprecipitated with anti-myc and western blotted
with anti-b-catenin. The astericks identify non-specific banding patterns. D) The interaction of luciferase-tagged b-catenin (b-catenin-Lux) with wild
type Nkd1 and Nkd2 (left panel) and Nkd1 mutants (right panel) was tested using the LUMIER assay in HEK293T cells. Numbers above Wild Type Nkd1
refer to amino acid positions in human Nkd1. Axin data has been previously reported [28] and is shown here for completeness. Data are shown as the
mean of 2 samples +/2 standard deviation (left panel) and interaction intensities of less than 50% (2), 50–75% (+) and .75% (++) of wild type are
indicated (right panel). clarity we refer to NHR1 as Naked Homology Region 1 (116–192aa), which encompasses the EF hand (143–154aa). The NHR1
region has also been referred to as NH2 [56] as well as EFX [10].
doi:10.1371/journal.pone.0018650.g005
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Figure S1 Nkd1 inhibits nuclear b-catenin. (A) Whole
embryo analysis of nuclear b-catenin staining as per Fig. 4.) (B)
Immunohistochemistry of Nkd1
GFP and Nkd1
N-GFP co-injections
with wnt8. Injections are labeled along the left side, staining is
identified along the top.
(TIF)
Figure S2 Dvl2 and b-catenin bind to similar domains
on Nkd1. HEK293T cells were transfected with luciferase-tagged
b-catenin (left panel) or Dvl2 (right panel) and the indicated
3XFlag-Nkd1 constructs. Cell lysates were subject to anti-Flag
immunoprecipitation and the presence of b-catenin or Dvl2 was
assessed by luciferase assay. Luciferase activity of the immuno-
precipitate was normalised to that of the total cell lysate (left panel)
or plotted separately (right panel). Data are the average of at least
4 independent experiments expressed as % wild type +/2 SEM
(left panel) or as the mean of 2 samples +/2 standard deviation of
a representative experiment (right panel).
(TIF)
Acknowledgments
We would like to thank members of the Solnica-Krezel, Coffey, Attisano
and Van Raay labs for support and valuable comments.
Author Contributions
Conceived and designed the experiments: TJVR JLF CL LA LSK RJC.
Performed the experiments: TJVR NJF BWM HM GL. Analyzed the data:
TJVR JLF CL BWM LA LSK RJC. Wrote the paper: TJVR LSK RJC.
References
1. Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, et al. (2009)
Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457: 608–611.
2. Behrens J, Lustig B (2004) The Wnt connection to tumorigenesis. Int J Dev Biol
48: 477–487.
3. Reya T, Clevers H (2005) Wnt signalling in stem cells and cancer. Nature 434:
843–850.
4. Fuchs E (2009) The tortoise and the hair: slow-cycling cells in the stem cell race.
Cell 137: 811–819.
5. Jones S, Chen WD, Parmigiani G, Diehl F, Beerenwinkel N, et al. (2008)
Comparative lesion sequencing provides insights into tumor evolution. Proc Natl
Acad Sci U S A 105: 4283–4288.
6. Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell
87: 159–170.
7. Chang JL, Chang MV, Barolo S, Cadigan KM (2008) Regulation of the
feedback antagonist naked cuticle by Wingless signaling. Dev Biol 321: 446–454.
8. Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell
127: 469–480.
9. Van Raay TJ, Coffey RJ, Solnica-Krezel L (2007) Zebrafish Naked1 and
Naked2 antagonize both canonical and non-canonical Wnt signaling. Dev Biol
309: 151–168.
10. Wharton KA, Jr., Zimmermann G, Rousset R, Scott MP (2001) Vertebrate
proteins related to Drosophila Naked Cuticle bind Dishevelled and antagonize
Wnt signaling. Dev Biol 234: 93–106.
11. Behrens J, Jerchow BA, Wurtele M, Grimm J, Asbrand C, et al. (1998)
Functional interaction of an axin homolog, conductin, with beta-catenin, APC,
and GSK3beta. Science 280: 596–599.
12. Chia IV, Costantini F (2005) Mouse axin and axin2/conductin proteins are
functionally equivalent in vivo. Mol Cell Biol 25: 4371–4376.
13. Schmidt C, Otto A, Luke G, Valasek P, Otto WR, et al. (2006) Expression and
regulation of Nkd-1, an intracellular component of Wnt signalling pathway in
the chick embryo. Anat Embryol (Berl) 211: 525–534.
14. Guo J, Cagatay T, Zhou G, Chan CC, Blythe S, et al. (2009) Mutations in the
human naked cuticle homolog NKD1 found in colorectal cancer alter Wnt/
Dvl/beta-catenin signaling. PLoS One 4: e7982.
15. Yan D, Wiesmann M, Rohan M, Chan V, Jefferson AB, et al. (2001) Elevated
expression of axin2 and hnkd mRNA provides evidence that Wnt/beta-catenin
signaling is activated in human colon tumors. Proc Natl Acad Sci U S A 98:
14973–14978.
16. Lei H, Juan AH, Kim MS, Ruddle FH (2007) Mouse naked cuticle 2 (mNkd2) as
a direct transcriptional target of Hoxc8 in vivo. J Exp Zool A Ecol Genet Physiol
307: 1–6.
17. Hu T, Li C, Cao Z, Van Raay TJ, Smith JG, et al. (2010) Myristoylated Naked2
antagonizes Wnt-beta-catenin activity by degrading Dishevelled-1 at the plasma
membrane. J Biol Chem 285: 13561–13568.
18. Cao Z, Li C, Higginbotham JN, Franklin JL, Tabb DL, et al. (2008) Use of
fluorescence-activated vesicle sorting for isolation of Naked2-associated,
basolaterally targeted exocytic vesicles for proteomics analysis. Mol Cell
Proteomics 7: 1651–1667.
19. Ding W, Li C, Hu T, Graves-Deal R, Fotia AB, et al. (2008) EGF receptor-
independent action of TGF-alpha protects Naked2 from AO7-mediated
ubiquitylation and proteasomal degradation. Proc Natl Acad Sci U S A 105:
13433–13438.
20. Li C, Franklin JL, Graves-Deal R, Jerome WG, Cao Z, et al. (2004)
Myristoylated Naked2 escorts transforming growth factor alpha to the
basolateral plasma membrane of polarized epithelial cells. Proc Natl Acad
Sci U S A 101: 5571–5576.
21. Li C, Hao M, Cao Z, Ding W, Graves-Deal R, et al. (2007) Naked2 acts as a
cargo recognition and targeting protein to ensure proper delivery and fusion of
TGF-alpha containing exocytic vesicles at the lower lateral membrane of
polarized MDCK cells. Mol Biol Cell 18: 3081–3093.
22. Yan D, Wallingford JB, Sun TQ, Nelson AM, Sakanaka C, et al. (2001) Cell
autonomous regulation of multiple Dishevelled-dependent pathways by
mammalian Nkd. Proc Natl Acad Sci U S A 98: 3802–3807.
23. Rousset R, Mack JA, Wharton KA, Jr., Axelrod JD, Cadigan KM, et al. (2001)
Naked cuticle targets dishevelled to antagonize Wnt signal transduction. Genes
Dev 15: 658–671.
24. Chan CC, Zhang S, Rousset R, Wharton KA, Jr. (2008) Drosophila Naked
cuticle (Nkd) engages the nuclear import adaptor Importin-alpha3 to antagonize
Wnt/beta-catenin signaling. Dev Biol 318: 17–28.
25. Rousset R, Wharton KA, Jr., Zimmermann G, Scott MP (2002) Zinc-dependent
interaction between dishevelled and the Drosophila Wnt antagonist naked
cuticle. J Biol Chem 277: 49019–49026.
26. Waldrop S, Chan CC, Cagatay T, Zhang S, Rousset R, et al. (2006) An
unconventional nuclear localization motif is crucial for function of the
Drosophila Wnt/wingless antagonist Naked cuticle. Genetics 174: 331–348.
27. Chan CC, Zhang S, Cagatay T, Wharton KA, Jr. (2007) Cell-autonomous,
myristyl-independent activity of the Drosophila Wnt/Wingless antagonist Naked
cuticle (Nkd). Dev Biol 311: 538–553.
28. Miller BW, Lau G, Grouios C, Mollica E, Barrios-Rodiles M, et al. (2009)
Application of an integrated physical and functional screening approach to
identify inhibitors of the Wnt pathway. Mol Syst Biol 5: 315.
29. Fan L, Collodi P (2006) Zebrafish embryonic stem cells. Methods Enzymol 418:
64–77.
30. Kane DA, Kimmel CB (1993) The zebrafish midblastula transition. Develop-
ment 119: 447–456.
31. Kelly GM, Greenstein P, Erezyilmaz DF, Moon RT (1995) Zebrafish wnt8 and
wnt8b share a common activity but are involved in distinct developmental
pathways. Development 121: 1787–1799.
32. Ramel MC, Lekven AC (2004) Repression of the vertebrate organizer by Wnt8
is mediated by Vent and Vox. Development 131: 3991–4000.
33. Shimizu T, Yamanaka Y, Ryu SL, Hashimoto H, Yabe T, et al. (2000)
Cooperative roles of Bozozok/Dharma and Nodal-related proteins in the
formation of the dorsal organizer in zebrafish. Mech Dev 91: 293–303.
34. Ryu SL, Fujii R, Yamanaka Y, Shimizu T, Yabe T, et al. (2001) Regulation of
dharma/bozozok by the Wnt pathway. Dev Biol 231: 397–409.
35. Schwarz-Romond T, Merrifield C, Nichols BJ, Bienz M (2005) The Wnt
signalling effector Dishevelled forms dynamic protein assemblies rather than
stable associations with cytoplasmic vesicles. J Cell Sci 118: 5269–5277.
36. Schwarz-Romond T, Fiedler M, Shibata N, Butler PJ, Kikuchi A, et al. (2007)
The DIX domain of Dishevelled confers Wnt signaling by dynamic
polymerization. Nat Struct Mol Biol 14: 484–492.
37. Hwang CS, Shemorry A, Varshavsky A (2010) N-terminal acetylation of cellular
proteins creates specific degradation signals. Science 327: 973–977.
38. Tsang M, Maegawa S, Kiang A, Habas R, Weinberg E, et al. (2004) A role for
MKP3 in axial patterning of the zebrafish embryo. Development 131:
2769–2779.
39. Angers S, Thorpe CJ, Biechele TL, Goldenberg SJ, Zheng N, et al. (2006) The
KLHL12-Cullin-3 ubiquitin ligase negatively regulates the Wnt-beta-catenin
pathway by targeting Dishevelled for degradation. Nat Cell Biol 8: 348–357.
40. Hino S, Michiue T, Asashima M, Kikuchi A (2003) Casein kinase I epsilon
enhances the binding of Dvl-1 to Frat-1 and is essential for Wnt-3a-induced
accumulation of beta-catenin. J Biol Chem 278: 14066–14073.
41. Peters JM, McKay RM, McKay JP, Graff JM (1999) Casein kinase I transduces
Wnt signals. Nature 401: 345–350.
42. McKay RM, Peters JM, Graff JM (2001) The casein kinase I family in Wnt
signaling. Dev Biol 235: 388–396.
43. Gao ZH, Seeling JM, Hill V, Yochum A, Virshup DM (2002) Casein kinase I
phosphorylates and destabilizes the beta-catenin degradation complex. Proc Natl
Acad Sci U S A 99: 1182–1187.
44. Wharton KA (2003) Runnin’ with the dvl: proteins that associate with dsh/dvl
and their significance to wnt signal transduction. Dev Biol 253: 1–17.
Nkd1 Antagonizes Nuclear Accumulation of b-Catenin
PLoS ONE | www.plosone.org 11 April 2011 | Volume 6 | Issue 4 | e1865045. Li FQ, Mofunanya A, Harris K, Takemaru K (2008) Chibby cooperates with
14-3-3 to regulate beta-catenin subcellular distribution and signaling activity.
J Cell Biol 181: 1141–1154.
46. Phelps RA, Chidester S, Dehghanizadeh S, Phelps J, Sandoval IT, et al. (2009) A
two-step model for colon adenoma initiation and progression caused by APC
loss. Cell 137: 623–634.
47. Cong F, Schweizer L, Varmus H (2004) Wnt signals across the plasma
membrane to activate the beta-catenin pathway by forming oligomers
containing its receptors, Frizzled and LRP. Development 131: 5103–5115.
48. Bilic J, Huang YL, Davidson G, Zimmermann T, Cruciat CM, et al. (2007) Wnt
induces LRP6 signalosomes and promotes dishevelled-dependent LRP6
phosphorylation. Science 316: 1619–1622.
49. Klimowski LK, Garcia BA, Shabanowitz J, Hunt DF, Virshup DM (2006) Site-
specific casein kinase 1epsilon-dependent phosphorylation of Dishevelled
modulates beta-catenin signaling. FEBS J 273: 4594–4602.
50. Faux MC, Coates JL, Catimel B, Cody S, Clayton AH, et al. (2008) Recruitment
of adenomatous polyposis coli and beta-catenin to axin-puncta. Oncogene 27:
5808–5820.
51. Zeng W, Wharton KA, Jr., Mack JA, Wang K, Gadbaw M, et al. (2000) naked
cuticle encodes an inducible antagonist of Wnt signalling. Nature 403: 789–795.
52. Zhang S, Cagatay T, Amanai M, Zhang M, Kline J, et al. (2007) Viable mice
with compound mutations in the Wnt/Dvl pathway antagonists nkd1 and nkd2.
Mol Cell Biol 27: 4454–4464.
53. Erter CE, Wilm TP, Basler N, Wright CV, Solnica-Krezel L (2001) Wnt8 is
required in lateral mesendodermal precursors for neural posteriorization in vivo.
Development 128: 3571–3583.
54. Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain SH, et al. (1993)
Association of the APC gene product with beta-catenin. Science 262:
1731–1734.
55. Barrios-Rodiles M, Brown KR, Ozdamar B, Bose R, Liu Z, et al. (2005) High-
throughput mapping of a dynamic signaling network in mammalian cells.
Science 307: 1621–1625.
56. Katoh M (2001) Molecular cloning, gene structure, and expression analyses of
NKD1 and NKD2. Int J Oncol 19: 963–969.
Nkd1 Antagonizes Nuclear Accumulation of b-Catenin
PLoS ONE | www.plosone.org 12 April 2011 | Volume 6 | Issue 4 | e18650